These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


208 related items for PubMed ID: 25014623

  • 21. Restoration of connexin 43 by Bowman-Birk protease inhibitor in M5076 bearing mice.
    Suzuki K, Yano T, Sadzuka Y, Sugiyama T, Seki T, Asano R.
    Oncol Rep; 2005 Jun; 13(6):1247-50. PubMed ID: 15870950
    [Abstract] [Full Text] [Related]

  • 22. Imbibition of soybean seeds in warm water results in the release of copious amounts of Bowman-Birk protease inhibitor, a putative anticarcinogenic agent.
    Palavalli MH, Natarajan SS, Wang TT, Krishnan HB.
    J Agric Food Chem; 2012 Mar 28; 60(12):3135-43. PubMed ID: 22372424
    [Abstract] [Full Text] [Related]

  • 23. Monoclonal antibodies against soybean Bowman-Birk inhibitor recognize the protease-reactive loops.
    Mao Y, Lai C, Vogtentanz G, Schmidt B, Day T, Miller J, Brandon DL, Chen D.
    Protein J; 2005 Jul 28; 24(5):275-82. PubMed ID: 16284725
    [Abstract] [Full Text] [Related]

  • 24. c-fos mRNA levels are reduced in the presence of antipain and Bowman-Birk inhibitor.
    Caggana M, Kennedy AR.
    Carcinogenesis; 1989 Nov 28; 10(11):2145-8. PubMed ID: 2509094
    [Abstract] [Full Text] [Related]

  • 25. In vivo anti-inflammatory efficacy of the combined Bowman-Birk trypsin inhibitor and genistein isoflavone, two biological compounds from soybean.
    Sadeghalvad M, Mohammadi-Motlagh HR, Karaji AG, Mostafaie A.
    J Biochem Mol Toxicol; 2019 Dec 28; 33(12):e22406. PubMed ID: 31593353
    [Abstract] [Full Text] [Related]

  • 26. Modulation of lung tumor development in mice with the soybean-derived Bowman-Birk protease inhibitor.
    Witschi H, Kennedy AR.
    Carcinogenesis; 1989 Dec 28; 10(12):2275-7. PubMed ID: 2591017
    [Abstract] [Full Text] [Related]

  • 27. Induction of apoptosis in the LNCaP human prostate carcinoma cell line and prostate adenocarcinomas of SV40T antigen transgenic rats by the Bowman-Birk inhibitor.
    Tang M, Asamoto M, Ogawa K, Naiki-Ito A, Sato S, Takahashi S, Shirai T.
    Pathol Int; 2009 Nov 28; 59(11):790-6. PubMed ID: 19883429
    [Abstract] [Full Text] [Related]

  • 28. Glycation affects differently the main soybean Bowman-Birk isoinhibitors, IBB1 and IBBD2, altering their antiproliferative properties against HT29 colon cancer cells.
    Olías R, Becerra-Rodríguez C, Soliz-Rueda JR, Moreno FJ, Delgado-Andrade C, Clemente A.
    Food Funct; 2019 Sep 01; 10(9):6193-6202. PubMed ID: 31501839
    [Abstract] [Full Text] [Related]

  • 29. Suppression of 3-methylcholanthrene-induced cellular transformation by timed administration of the Bowman-Birk protease inhibitor.
    St Clair WH.
    Carcinogenesis; 1991 May 01; 12(5):935-7. PubMed ID: 2029760
    [Abstract] [Full Text] [Related]

  • 30. Interleukin-10 plays a crucial role in suppression of experimental autoimmune encephalomyelitis by Bowman-Birk inhibitor.
    Dai H, Ciric B, Zhang GX, Rostami A.
    J Neuroimmunol; 2012 Apr 01; 245(1-2):1-7. PubMed ID: 22365083
    [Abstract] [Full Text] [Related]

  • 31. The anti-proliferative effect of TI1B, a major Bowman-Birk isoinhibitor from pea (Pisum sativum L.), on HT29 colon cancer cells is mediated through protease inhibition.
    Clemente A, Carmen Marín-Manzano M, Jiménez E, Carmen Arques M, Domoney C.
    Br J Nutr; 2012 Aug 01; 108 Suppl 1():S135-44. PubMed ID: 22916809
    [Abstract] [Full Text] [Related]

  • 32. Bowman-Birk inhibitors from legumes as colorectal chemopreventive agents.
    Clemente A, Arques Mdel C.
    World J Gastroenterol; 2014 Aug 14; 20(30):10305-15. PubMed ID: 25132747
    [Abstract] [Full Text] [Related]

  • 33. Bowman-Birk inhibitor suppresses autoimmune inflammation and neuronal loss in a mouse model of multiple sclerosis.
    Touil T, Ciric B, Ventura E, Shindler KS, Gran B, Rostami A.
    J Neurol Sci; 2008 Aug 15; 271(1-2):191-202. PubMed ID: 18544456
    [Abstract] [Full Text] [Related]

  • 34. Soybean-derived Bowman-Birk inhibitor (BBI) blocks HIV entry into macrophages.
    Ma TC, Le Guo, Zhou RH, Wang X, Liu JB, Li JL, Zhou Y, Hou W, Ho WZ.
    Virology; 2018 Jan 01; 513():91-97. PubMed ID: 29040829
    [Abstract] [Full Text] [Related]

  • 35. Role of serine proteases in inflammation: Bowman-Birk protease inhibitor (BBI) as a potential therapy for autoimmune diseases.
    Safavi F, Rostami A.
    Exp Mol Pathol; 2012 Dec 01; 93(3):428-33. PubMed ID: 23022357
    [Abstract] [Full Text] [Related]

  • 36. Bowman-Birk inhibitor concentrate reduces colon inflammation in mice with dextran sulfate sodium-induced ulcerative colitis.
    Ware JH, Wan XS, Newberne P, Kennedy AR.
    Dig Dis Sci; 1999 May 01; 44(5):986-90. PubMed ID: 10235608
    [Abstract] [Full Text] [Related]

  • 37. Suppression of dimethylhydrazine-induced carcinogenesis in mice by dietary addition of the Bowman-Birk protease inhibitor.
    St Clair WH, Billings PC, Carew JA, Keller-McGandy C, Newberne P, Kennedy AR.
    Cancer Res; 1990 Feb 01; 50(3):580-6. PubMed ID: 2297699
    [Abstract] [Full Text] [Related]

  • 38. A proteolytic activity in a human breast cancer cell line which is inhibited by the anticarcinogenic Bowman-Birk protease inhibitor.
    Moy LY, Billings PC.
    Cancer Lett; 1994 Oct 14; 85(2):205-10. PubMed ID: 7954338
    [Abstract] [Full Text] [Related]

  • 39. Single-dose administration of Bowman-Birk inhibitor concentrate in patients with oral leukoplakia.
    Armstrong WB, Kennedy AR, Wan XS, Atiba J, McLaren CE, Meyskens FL.
    Cancer Epidemiol Biomarkers Prev; 2000 Jan 14; 9(1):43-7. PubMed ID: 10667462
    [Abstract] [Full Text] [Related]

  • 40. Soybean Bowman-Birk protease inhibitor is a highly effective inhibitor of human mast cell chymase.
    Ware JH, Wan XS, Rubin H, Schechter NM, Kennedy AR.
    Arch Biochem Biophys; 1997 Aug 01; 344(1):133-8. PubMed ID: 9244390
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 11.